Loading clinical trials...
Loading clinical trials...
The Impact and Outcomes of Combined Cerebrolysin and Amantadine Sulfate Administration on Management of Patients With Traumatic Brain Injury in the ICU
Conditions
Interventions
Cerebrolysin
amantadine sulfate
Locations
1
Egypt
Faculty of medicine - Ain shams university
Cairo, Egypt
Start Date
September 1, 2023
Primary Completion Date
May 30, 2025
Completion Date
August 1, 2025
Last Updated
November 19, 2025
NCT04521881
NCT07455136
NCT06725108
NCT06734026
NCT07357090
NCT06467708
Lead Sponsor
Ain Shams University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions